Disinfo Docs Land Public Health Jobs; Pediatrician Faces School Board Ouster medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Zelira Therapeutics closes out FY21 with record cash receipts ahead of product launches
The cannabinoid medicines developer brought in more than A$300,000 from customers over FY21’s final quarter, marking the best quarterly result on record. Zelira has closed out the 2021 financial year with a record A$311,000 in cash receipts.
Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF) has capped off the 2021 financial year with record cash receipts as it looks ahead to product launches later this year.
The cannabinoid medicines developer finished the June quarter with A$311,000 in cash receipts up 38% on the March quarter’s A$225,000 result.
In today’s quarterly report, Zelira chalked up the record receipts to sales growth across its SprinjeneCBD toothpaste line, clinical trial management and product licensing fees from partner Levin Health Limited.
Capstar Ventures Raises $41 3 Million Inaugural Fund to Invest in Innovative Consumer Companies siliconhillsnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siliconhillsnews.com Daily Mail and Mail on Sunday newspapers.
Developing New Diagnostic Strategies to Prevent DSA-mediated Tissue Injury in Solid Organ Transplantation
AUSTIN, Texas and CAMBRIDGE, U.K., July 21, 2021 (SEND2PRESS NEWSWIRE) Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The University of Cambridge Abdominal Transplant Centre at Addenbrooke’s Hospital, to develop new diagnostic strategies for DSA monitoring and characterization in transplantation.
The research is being led by Dr. Vasilis Kosmoliaptsis, Honorary Consultant Abdominal Transplant and HPB Surgeon, and Dr. Rico Buchli, Vice President Products and Services and Director of Research at PTS and its parent company, Pure Protein, LLC. The research project aims to investigate the relationship between alloantibody-HLA binding streng
Pure Transplant Solutions LLC Collaborates with Dept of Surgery at University of Cambridge UK on HLA Research massachusettsnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massachusettsnewswire.com Daily Mail and Mail on Sunday newspapers.